- PCOS is renamed PMOS to reflect its systemic metabolic and hormonal impact
- The new term highlights polyendocrine, metabolic, and ovarian involvement
- Existing PCOS diagnoses remain valid with no immediate treatment changes
For many years, millions of women worldwide have been aware of PCOS, or Polycystic Ovary Syndrome. It is associated with irregular periods, acne, weight gain, fertility problems, and hormone imbalance, making it one of the most common hormonal conditions affecting women of reproductive age.
Global specialists have now formally announced that PCOS will now be known as PMOS, or Polyendocrine Metabolic Ovarian Syndrome. In an effort to give the disorder a name that more accurately reflects how it affects the entire body, not just the ovaries, the decision was made following more than ten years of international discussion and research.
Naturally, women who have already received a diagnosis have questioned the announcement. "Will my diagnosis now shift from PCOS to PMOS?" is one of the most common concerns.
The condition itself does not change, so the short answer is no. The new nomenclature primarily alters how medical professionals and healthcare institutions define and understand the condition.
Why Was PCOS Renamed?
For a long time, the term "Polycystic Ovary Syndrome" has been considered misleading and inadequate.
Ovarian cysts are not seen in many women diagnosed with PCOS. However, some women may have ovaries that appear cystic on ultrasound without actually having the condition. This frequently led to confusion during diagnosis.
Additionally, experts believed that the previous terminology overemphasised the reproductive aspect of the condition while neglecting its broader effects on metabolism, hormones, skin health, mental health, and cardiovascular risk.
The new term, PMOS, attempts to correct that.
The word:
- Polyendocrine highlights the involvement of multiple hormones
- Metabolic focuses on insulin resistance and metabolic health
- Ovarian continues to acknowledge reproductive involvement
The new terminology reflects the fact that this is a condition affecting the entire body, not just the ovaries.
Does This Name Change Make My Current Diagnosis Invalid?
No, the name change is not a reason for women who have already been diagnosed with PCOS to panic or undergo retesting immediately.
Over the coming years, doctors are expected to gradually adopt the name PMOS. Existing PCOS-related medical records, medications, scans, and treatment plans will continue to remain valid.
The condition itself has not changed overnight. What is evolving is the way the disorder is understood and classified in medicine.
In practical terms:
- Your symptoms remain the same
- Your treatment may remain the same
- Your diagnosis remains medically recognised
- The terminology used by healthcare providers may gradually shift from PCOS to PMOS
Experts expect a transition period until around 2028 for global adoption.
Why PMOS Is Considered a More Accurate Name
One of the major reasons behind the renaming is the growing understanding that the condition affects multiple systems in the body.
PMOS is now increasingly recognised as a metabolic and endocrine disorder that can influence:
- Hormones
- Insulin levels
- Weight
- Skin health
- Ovulation
- Fertility
- Mood and mental health
- Heart health
Many women with the condition experience insulin resistance, where the body struggles to use insulin properly. This can increase the risk of:
- Prediabetes
- Type 2 diabetes
- High cholesterol
- Obesity
- Cardiovascular disease
Some women may also experience:
- Acne
- Excess facial hair
- Hair thinning
- Fatigue
- Anxiety and depression
The older name failed to fully capture these wider health concerns.
Why the Focus on Metabolic Health Matters
The inclusion of the word "metabolic" is one of the most important changes in the new name.
Doctors now believe that insulin resistance and chronic inflammation play a major role in the development of the condition. In many women, metabolic dysfunction may begin long before reproductive symptoms become obvious.
This broader understanding may improve:
- Early diagnosis
- Screening for diabetes and heart disease
- Long-term management
- Lifestyle intervention
- Multidisciplinary care
It may also encourage women to seek medical help earlier instead of dismissing symptoms as "normal hormonal problems".
Will Treatment Change?
For most women, treatment will continue to focus on symptom management and metabolic health.
Depending on symptoms, treatment may include:
- Lifestyle changes
- Weight management
- Exercise
- Dietary modifications
- Hormonal treatment
- Fertility support
- Blood sugar management
The new name may encourage doctors to take a more comprehensive approach instead of focusing only on irregular periods or fertility.
Women may increasingly receive support not only from gynaecologists, but also from:
- Endocrinologists
- Nutritionists
- Dermatologists
- Mental health professionals
This multidisciplinary approach is one of the major goals behind the transition from PCOS to PMOS.
What Symptoms Should Women Continue to Watch For?
Even with the name change, the common warning signs remain similar.
These include:
- Irregular or missed periods
- Difficulty losing weight
- Acne
- Excess facial or body hair
- Hair thinning
- Difficulty conceiving
- Darkening of the skin around the neck or underarms
- Fatigue
- Mood changes
Women experiencing these symptoms should continue seeking medical advice regardless of whether the condition is referred to as PCOS or PMOS.
A Shift in Understanding, Not Just Terminology
The transition from PCOS to PMOS represents more than just a change in terminology. It reflects a broader shift in the medical understanding of women's hormonal and metabolic health.
For years, many women with the condition felt misunderstood, underdiagnosed, or treated only for visible symptoms. The new terminology aims to encourage more comprehensive care and acknowledge the full complexity of the disorder.
There is no need for concern among women who have already been diagnosed. Existing diagnoses remain valid and recognised. However, future patients may benefit from earlier detection, more holistic treatment, and better long-term health support because of the broader understanding reflected in the term PMOS.
Ultimately, the renaming sends an important message: this condition involves far more than ovarian cysts alone.
(By Dr. Arun Mukka, Sr. Consultant Endocrinologist, Yashoda Hospitals, Hyderabad)
Disclaimer: The opinions expressed within this article are the personal opinions of the author. NDTV is not responsible for the accuracy, completeness, suitability, or validity of any information on this article. All information is provided on an as-is basis. The information, facts or opinions appearing in the article do not reflect the views of NDTV and NDTV does not assume any responsibility or liability for the same.
